Pascal Apostolides holds a B.Sc. degree in Chemistry, a B.A. in Economic Geography, and a post-graduate degree in Pharmaceutical Chemistry from the University of Manitoba, Winnipeg, Canada. He also received an M.Sc. in Environmental Chemistry from the University of Strathclyde, Glasgow, Scotland.
His long career in the pharma industry dates back in 1986 as Sales Representative in the Diagnostic Division Department of Abbott in Thessaloniki. In only two years’ time, he is appointed Project Manager in Athens and in 1990 he is promoted to the position of European Product Manager based in Germany. In 1996, he assumes the position of Marketing Director of Abbott Diagnostics Division in Germany, becoming the first non-German ever to hold the specific position. From 1997 up to January 2001, Pascal Apostolides joins Abbott International Division at Abbott Park in Chicago, as Commercial Director Europe.
In 2001 until the end of 2012, he held the position of General Manager of Abbott Laboratories (Hellas) and as of January 2013 after Abbott’s separation into two individual companies, Pascal Apostolides becomes the General Manager of AbbVie, an independent global biopharmaceutical which retains in its portfolio innovative medicines for serious and chronic diseases.
He is alternate President of the Hellenic Association of Pharmaceutical Companies (SFEE) and Vice President of the BoD of SFEE. Member of the Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA) as well as President of the Pharma Committee of the Hellenic-American Chamber of Commerce (AmCham) and also Member of the BoD of AmCham.